Introduction
Advancements in developmental biology and regenerative medicine have helped produce cell-based therapies to treat retinal degeneration, neurodegeneration, cardiopathies, and other diseases by replacing damaged or degenerative native tissue with a new functional implant developed in vitro. Induced pluripotent stem cells (iPSCs) have extended the potential of cell therapies to permit transplantation of autologous tissues (1) . However, as these autologous cell therapies are translated from the laboratory to the clinic, barriers to large-scale biomanufacturing have become evident (2) . Often, cell function is determined in the laboratory using sophisticated assays, including electrophysiology, ELISAs, immunolabeling, small molecule quantification, and DNA/RNA-based assays. These assays require a trained user, are low throughput, expensive, endpoint, and/ or are time consuming. Thus, they are challenging to implement under current good manufacturing practices (cGMP) which are required to produce any cell-therapy product (3) . Therefore, clinical translation of any iPSC-based therapy is made more challenging due to the scarcity of noninvasive, automated, fast, and robust assays (2) .
Here, a methodology was developed that uses quantitative bright-field absorbance microscopy (QBAM), which is an auto-mated method of capturing images that are reproducible across different microscopes, and neural networks to noninvasively predict tissue function. Clinical-grade iPSC-derived retinal pigment epithelial cells (iPSC-RPE) from age-related macular degeneration (AMD) patients and healthy donors were used as a model system to determine whether tissue function could be predicted from bright-field microscopy images.
The RPE is a cellular monolayer, and RPE are of clinical interest, as shown by the fact that at least 11 investigational new drug-enabling (IND-enabling) or phase I clinical trial stage studies are using RPE to treat AMD (4) . Additionally, the appearance of RPE cells within the monolayer is known to be critical to RPE function (5) (6) (7) and recently a phase I clinical trial used visual inspection of RPE by an expert technician as a biomanufacturing release criterion for implantation (8) . RPE cell appearance is largely dictated by the maturity of junctional complexes between neighboring RPE cells and the characteristic pigmented appearance from melanin production (9) . The junctional complex is linked to tissue maturity and functionality, including barrier function (transepithelial resistance [TER] and transepithelial potential [TEP] measurements) (10) and polarized secretion of growth factors (ELISA) (9) . Thus, cell appearance and function are correlated and may be predictive of each other.
The variability of transmitted light microscopy images makes them challenging to use for automated cell analysis and segmentation (11, 12) . Thus, the methodology developed in this study consists of 2 components. The first is QBAM. The second component is artificial intelligence, which uses QBAM images to predict multicellular function. The artificial intelligence techniques were split into the categories of deep neural networks (DNNs) and traditional machine learning (TML). These techniques were chosen because of the high accuracy achieved in recent biomedical classi-Increases in the number of cell therapies in the preclinical and clinical phases have prompted the need for reliable and noninvasive assays to validate transplant function in clinical biomanufacturing. We developed a robust characterization methodology composed of quantitative bright-field absorbance microscopy (QBAM) and deep neural networks (DNNs) to noninvasively predict tissue function and cellular donor identity. The methodology was validated using clinical-grade induced pluripotent stem cell-derived retinal pigment epithelial cells (iPSC-RPE). QBAM images of iPSC-RPE were used to train DNNs that predicted iPSC-RPE monolayer transepithelial resistance, predicted polarized vascular endothelial growth factor (VEGF) secretion, and matched iPSC-RPE monolayers to the stem cell donors. DNN predictions were supplemented with traditional machine-learning algorithms that identified shape and texture features of single cells that were used to predict tissue function and iPSC donor identity. These results demonstrate noninvasive cell therapy characterization can be achieved with QBAM and machine learning.
Deep learning predicts function of live retinal pigment epithelium from quantitative microscopy org/10.1172/JCI131187DS1). In this study, 3 different band-pass filters were used for imaging, but the method scales to any number of wavelengths. QBAM imaging was implemented as a plugin for Micromanager (for microscopes with available hardware) or a modular python package (for microscopes not supported by Micromanager), so that the user needed to only push a few buttons to obtain QBAM images.
Analysis of QBAM images was performed at the field of view (FOV) scale or the single-cell scale ( Figure 1B) . At both scales, DNNs were used for analysis, but for different purposes. The DNNs at the FOV scale were designed to directly predict 2 things: the outcome of functional/maturity assays (DNN-F, Supplemental Figure 2 , A and B) or whether 2 sets of QBAM images came from the same donor (DNN-I). No image processing was performed prior to feeding images into DNN-F or DNN-I.
Single-cell analysis began with a DNN that identified cell borders in QBAM images (DNN-S) (Supplemental Figure 2C ). Next, fication (13) and regression applications (14) , their computational speeds for industrial scalability (15, 16) , and their robustness to noise/variability (17, 18) . We anticipate that the speed, reproducibility, and accuracy of these noninvasive, automated methods will aid in scaling the biomanufacturing process as cell therapies translate from the laboratory to the clinic.
Results
Methodology overview and test case description. QBAM was developed to achieve reproducibility in bright-field imaging across different microscopes. QBAM converts pixels from relative intensity units to absorbance units, an absolute measure of light attenuation ( Figure 1A ). To improve reproducibility of imaging, QBAM calculates statistics on images in real time as they are captured to ensure that the absorbance value measured at every pixel has a 95% CI of 10 milli-absorbance units (mAU) (Supplemental Figure 1 ; supplemental material available online with this article; https://doi. albinism disorder (OCA), and AMD. The iPSC-RPE from healthy donors were imaged as they matured, while cells from AMD and OCA donors were imaged at a terminal time point once they had reached maturity. These 2 experimental designs were used to address 2 different use cases for the platform: (a) Noninvasively predicting iPSC-RPE function throughout the long culture to reduce the total number of replicates needed and provide more comprehensive/continuous assessment of samples and (b) noninvasively providing assurance of tissue function, tissue identity, and determination of whether tissue is an outlier from all other replicates on the implant that is being placed into patients on the visual features of individual cells were extracted from the QBAM images using the web image processing pipeline (WIPP, extracted features in Supplemental Table 1 and ref. 19 ). The extracted visual features were then used to train TML algorithms to predict a variety of tissue characteristics, including function, origin of the donor the cells, and developmental outliers (abnormal cell appearance). TML algorithms were then used to identify critical cell features that contributed to the prediction of tissue characteristics. To demonstrate the effectiveness of the imaging and analysis method, a proof of principle study was carried out on iPSC-RPE from the following donor types: healthy, oculocutaneous ent patients with OCA (a disease known to reduce iPSC-RPE pigmentation). Mutant loci in OCA iPSC-RPE were sequenced to confirm the albinism type (OCA1A or OCA2) and the disease severity. OCA1A iPSC-RPE produced no melanin (OCA8 and OCA26) and thus had the lowest image absorbance. OCA2 patients had a range of phenotypes from moderate (OCA103 and OCA9) to mild (OCA71), which corresponded with absorbance measures made by QBAM ( Figure 2D ). Despite iPSC-RPE from OCA1A patients producing low levels of pigment, the absorbance values were 2× higher than the lowest sensitivity of QBAM (10 mAU). Taken together, these data demonstrate the accuracy, reproducibility, and sensitivity of QBAM imaging. Methodology to predict iPSC-RPE function from absorbance images. iPSC-RPE from healthy donors (healthy-1, healthy-2) were imaged to determine whether QBAM imaging affected cell maturation and could measure a large range in variation of iPSC-RPE pigmentation. This was done using 3 culture conditions: (a) control iPSC-RPE (no treatment), (b) iPSC-RPE treated with a known inducer of RPE maturation (aphidicolin), and (c) iPSC-RPE treated with a known inhibitor of RPE maturation (hedgehog pathway inhibitor-4 [HPI4]) (21) .
Control and aphidicolin-treated iPSC-RPE were found to mature as expected with increasing absorbance over the 8-week culture, while HPI4-treated iPSC-RPE had a decreasing trend in absorbance over time (healthy-2 is shown in Figure 3 , A and B, and healthy-1 in Supplemental Figure 3 , A and B). Higher mRNA and protein expression of maturation markers were found in control and aphidicolin-treated iPSC-RPE than in HPI4-treated iPSC-RPE ( Figure 3C and Supplemental Figure 3 , D-F). The baseline electrical response (TEP and TER) and its change to physiological treatments of 5 mM to 1 mM potassium (K + ) or 100 μM adenosine triphosphate (ATP) on the apical side was significantly greater in aphidicolin-treated iPSC-RPE and significantly lower in HPI4-treated iPSC-RPE relative to control ( Figure 3D and Supplemental Figure  3C ). Further, iPSC-RPE maturation was evident from the presence of dense, native-like apical processes (Supplemental Figure 3 , G and H, and ref. 21) . From this set of experiments, it was concluded that (a) iPSC-RPE produced in clinical grade conditions had a mature epithelial phenotype, (b) weekly QBAM imaging did not affect iPSC-RPE maturation, and (c) differences in pigmentation between mature (control and aphidicolin) and immature (HPI4) iPSC-RPE could be quantified with QBAM imaging.
The capacity to predict iPSC-RPE monolayer function and phenotype from QBAM images of iPSC-RPE was assessed next. For healthy donor iPSC-RPE, mean QBAM pixel value had little correlation with TER ( Figure 3F , R 2 = 0.19). However, the TER predictions by DNN-F highly correlated with actual TER values for the same samples ( Figure 3G , R 2 = 0.97) and these predictions had a RMSE of 70.6 Ω·cm 2 . To incorporate this methodology into a biomanufacturing setting, a TER of 400 Ω·cm 2 was used as a stringent threshold to classify iPSC-RPE monolayers as immature (<400 Ω·cm 2 ) or mature (>400 Ω·cm 2 ). Red-shaded regions in Figure 3F indicate TER values associated with immature iPSC-RPE, and red-shaded regions in Figure 3G indicate false positives and negatives. Based on this TER threshold, the DNN-F was 94% accurate, sensitivity was 100%, and specificity was 90% for classifying iPSC-RPE maturity. Similar trends were observed for day that it will be implanted. The assessment of cells was done using TML algorithms and DNNs (rather than traditional statistical approaches) due to the large heterogeneity of cells across scales (within a well, across replicates, between cultures, across clones, and across donors). To both assess and incorporate this heterogeneity, high-dimensional models were needed for accurate prediction of cell function, identity, and determination of whether cells were outliers. iPSC-RPE from 5 different OCA patients and 2 healthy donors were imaged using QBAM to determine the sensitivity of the imaging method to biological variation and naturally low levels of melanin in OCA iPSC-RPE. In addition to weekly imaging, iPSC-RPE from healthy donors were assessed for TER and polarized VEGF secretion. TER is a measure of RPE maturity that increases as tight junctions form between neighboring cells. Polarized VEGF secretion is a measure of RPE function, where more VEGF is secreted on the basal side relative to the apical side of the cell monolayer (VEGF-ratio). Finally, 8 iPSC-RPE clones were derived from 3 AMD donors using clinical-grade protocols. Here, clinical grade refers to production of cells using xenogeneic free reagents and cGMP compliant production processes. QBAM imaging was carried out on AMD iPSC-RPE once they had reached maturity.
Accuracy, reproducibility, and sensitivity of QBAM. QBAM imaging was validated with a combination of reference neutral density (ND) filters and biological samples. ND filters with known absorbance values were used as a reference to validate QBAM imaging by comparing absorbance measured on a UV Vis spectrometer to absorbance measured using QBAM imaging. Absorbance measured with QBAM imaging strongly correlated with absorbance measured by the spectrometer across the visible spectrum ( Figure  2A , R 2 > 0.999). To further validate the method, reproducibility of QBAM on ND filters was determined across 3 additional microscopes, each equipped with different filters, objectives, and light sources. The root mean squared error (RMSE) across all filters and microscopes was 66 mAU or approximately 4.4% at the highest absorbance value measured ( Figure 2B) .
QBAM imaging was then tested on live, progressively maturing iPSC-RPE derived from 2 different healthy donors. As expected from published literature (20) , a general trend of increasing mean absorbance as time progressed was found ( Figure 2C ). To determine how sensitive QBAM imaging was with respect to iPSC-RPE pigmentation, QBAM was used to image iPSC-RPE from 5 differ- VEGF-ratios, where the polarized release of VEGF did not correlate well with QBAM mean pixel value (Supplemental Figure  4 , A and B), but DNN-F predictions correlated highly with VEGFratio measurements (R 2 = 0.89) and the RMSE of the VEGF-ratio predictions was less than 1.0 (Supplemental Figure 4C ). The accuracy, sensitivity, and specificity of the VEGF-ratio were all 100% (Supplemental Figure 4C ; samples with VEGF-ratio < 3.0 were considered immature). From these experiments, we conclude that (a) QBAM images of living cells can be used to predict TER and VEGF-ratios with high fidelity and (b) QBAM imaging could be used as a noninvasive means of functional validation of cells in lieu of measuring TER and/or VEGF-ratio.
Extraction of single-cell features from live QBAM images of iPSC-RPE monolayers. DNNs are known to have superior pre- Table 2 ) showed a difference of 7.94% ± 4.42% (mean ± SD) between the feature histograms with good pixel-wise agreement (F-2 = 0.71) ( Table 1) . QBAM imaging and live-cell segmentation allow for hundreds of cell-image features to be measured and tracked noninvasively on individual cells throughout iPSC-RPE maturation. Thus, the trained DNN-S was used to segment QBAM images of living iPSC-RPE (healthy-1 and healthy-2 donors) treated with aphidicolin, HPI-4, or nothing (control). Previously published cell image features (22) (23) (24) and intensity metrics (20) known to correlate to RPE maturation and health were then assessed for significance. Figure 4C shows the average number of neighbors (22, 23) each iPSC-RPE cell had as a function of drug treatment and shows that HPI4 had a significantly lower (P < 0.001) mean number of neighbors across all time points. Importantly, this method allows for unprecedented hierarchical granularity to the data; enabling not just whole well "bulk" tissue measurements ( Figure 4C ), but also as a function of FOV, as shown in Figure  4D , or at an individual cell level, as shown in Figure 4E . Figure 4F shows clustering of treatments based on 2 features known to be important to RPE maturation and health, cell area (22, 24) and mean cell intensity (20) . Figure 4Gshows cell minimum intensity, a new metric related to iPSC-RPE function identified using TML in Figure 4G Figure 5A shows TER predictions for the MLP, the most accurate TML approach (RMSE = 84.7 Ω·cm 2 and R 2 = 0.94). The red shaded regions represent false positives/negatives when using 400 Ω·cm 2 as a quality assurance (QA) or quality control (QC) threshold. The MLP had an accuracy of 94%, sensitivity of 100%, and specific- Supplemental Figure 6B ), but DNN-F had a 1.4× lower RMSE (Supplemental Figure 6C) . The benefit of predicting iPSC-RPE monolayer function from cell features is the ability to determine single-cell characteristics that indicate tissue-level function. For each TML method, cell fea-ity of 90% (Supplemental Figure 6A ). However, a comparison of all algorithms ( Table 2 and Supplemental Figure 6A ) showed the DNN-F was the most accurate predictor of TER, with the MLP's RMSE being 14.1 Ω·cm 2 higher than DNN-F ( Table 2) . For VEGF-ratio predictions, RF was the best TML method (RF, DNN-F, deep learning network shown in Figure 2 . Table 4 shows all combinations in detail). The mean TER RMSE was 86.9 Ω·cm 2 ± 14.3 Ω·cm 2 (Supplemental Table 4 ) across all clone subsets, showing that the prediction error was similar when scaled to a larger donor subset (8 AMD-iPSC-RPE samples; Figure  6 ) as compared with a single sample (healthy-2; Figure 5 ). From the measured and predicted values, a 95% CI was constructed and is shown as the blue regions in Figure 6C and Supplemental Figure  7C . iPSC-RPE falling outside of this region could be considered as "out of specification" in a biomanufacturing environment and would be recommended for further testing. Finally, the most important cell features for predicting AMD-iPSC-RPE monolayer TER ( Figure 6D ) and VEGF-ratio across all donor/sample combinations were assessed to determine whether features used to predict AMD-iPSC-RPE function were similar to those of healthy-2 ( Figure 5 ). Interestingly, only 4 features overlapped between these 2 groups: Zernike n4-m0 polynomial (shape 1), mass displacement (intensity 2), and the third inverse difference moment at 135° (texture 2) and at 45° (texture 1). Overall, the models derived from the clinical grade iPSC-RPE images were able to predict iPSC-RPE phenotype across multiple donors/ samples and to determine the common cell-image features of living cells across multiple donors that predict iPSC-RPE monolayer function. Further, the differences in the feature importance from healthy-2 and the AMD-iPSC-RPE suggest there might be both donor-specific features for predicting function and features that are common to multiple donors.
Classification of developmental outliers and identity of iPSC-RPE donors using QBAM. QBAM images were used to determine whether there were any developmental outliers based on cellimage features in the 8 clinical grade iPSC-RPE samples from 3 AMD patients. Developmental outliers are defined as an intradonor comparison in which iPSC-RPE monolayers that are different from other iPSC-RPE monolayers based on cell image features may warrant additional analysis to determine whether the monolayer developed properly. Figure 7A shows the principle component analysis of cell-image features from the QBAM images of the AMD donor/sample preparation. iPSC-RPE derived from a given donor clustered well together based on cell-image features, except AMD1 clone A (1A) and AMD3 clone A (3A), as identified in the hierarchical dendrogram of the PCA shown in Figure 7B . Analysis of clone 1A iPSC-RPE showed 894 changes in the oncoexome as compared with the starting donor material as shown by Sharma et al. (25) . Clone 3A iPSC-RPE was found to have a lower pigment level than its "sibling" iPSC-RPE (Figure 6B) . When the cell-image features were analyzed, the cell pigmentation and shape were found to be the 2 most dominant feature classes in identifying these iPSC-RPE as outliers; a full description of features can be seen in the online dataset (http:// isg.nist.gov/deepzoomweb/data/RPEimplants).
For each iPSC-RPE monolayer, the cell donor identity was predicted from QBAM images using multiple TML models. Additionally, a new DNN (DNN-I) was developed to determine whether 2 different iPSC-RPE images had the same identity (Tables 3 and  5 ). Donor identity is defined as an interdonor comparison to deter-tures were ranked by importance. When comparing all TML models, there was similarity in the most important features for predicting TER ( Figure 5 , B and C) or VEGF-ratio regardless of which TML method was used. Interestingly, key cell image features for predicting TER were spread across intensity, texture, and shape of cells ( Figure 5B ) Of the 10 most important features, 3 related to the shape of cells, 3 to the intensity of pigment within cells, and 4 described the distribution of pigment within RPE (texture). Supplemental Table 3 and the online data (see details in regarding data and software availability in the Methods section) shows what metrics specifically these features represent and their 95% CI for each time point and drug treatment.
Taken together, the above indicates that using live-cell segmentation, feature extraction, and TML, tissue TER, and VEGF-ratio can be predicted with a level of accuracy approaching the prediction accuracy of DNNs to analyze QBAM images. The benefit to TML methods compared with DNNs is that TML models can identify discrete cell features that indicate iPSC-RPE monolayer function. This allows manufacturers and clinicians to better understand the models, determine why a culture has been predicted to have low function, and perhaps develop mitigation strategies based on the parameters that have shown to be predictive of the phenotype.
Accuracy of function predictions is robust across multiple clinicalgrade AMD patient-derived iPSC-RPE. To determine whether the methodology was robust across multiple donors and multiple preparations, DNN-F and TMLs were used to predict TER and VEGF-ratios of clinical grade iPSC-RPE from 3 AMD patients across 8 iPSC clones. Figure 6A shows representative absorbance images of 1 iPSC-RPE sample from each of the AMD donors and corresponding SEM images of iPSC-RPE apical processes, confirming iPSC-RPE polarized phenotype. Monolayer maturation was assessed by TER ( Figure 6B ) and VEGF-ratio (Supplemental Figure 7A ) as well as the assays shown in Sharma et al. (25) . Mean QBAM pixel values of iPSC-RPE were measured for fully mature AMD-iPSC-RPE. As with the healthy donors, mean absorbance did not correlate well with TER ( Figure 7B , R 2 = 0.015) or VEGF-ratio (Supplemental Figure 7A , R 2 = 0.50). However, the RF model was able to predict TER to a similar degree of accuracy (RMSE = 70.9 Ω·cm 2 , R 2 = 0.92) as seen with healthy donors ( Table  2 ). DNN-F was also used to model TER, and the predicted versus actual values correlated well (R 2 = 0.91, Supplemental Figure 7B ).
To further assess the robustness of the methodology, TML models were trained on different combinations of AMD-iPSC- tions ( Figure 7C ) and consisted of features that were different from the features used to identify tissue function (compare Figure 5 , B and C, with Figure 7C ) and developmental outliers. A general difference between the top 50 features used in each application were as follows: shape features were important to identify clones as outliers (23 of the top 50 features); texture features were important for donor classification of clones (25 of the top 50 features); and shape and texture features were important to classify iPSC-RPE function (40 of the top 50 features).
Discussion
Absorbance imaging. Data inputs are critical to successful analysis. Thus, the methodology developed here starts with a rigorous, reproducible absorbance imaging method using a bright-field microscope. Absorption imaging has been reported in the literature (26) (27) (28) , but the QBAM technology developed here can be implemented on any standard bright-field microscope, and it uses real-time, automated, statistically robust methods to provide high confidence in image quality and reproducibility. The advantage to using absorbance rather than raw pixel intensities is that absorbance is an absolute measure of light attenuation (29) . Raw pixel intensities can vary with microscope configuration and settings (e.g., uneven lighting, bulb intensity and spectrum, camera, etc.) that make comparison of images difficult even when the images are captured on the same microscope. Converting to absorbance values overcomes many issues related to image reproducibility (explained in more detail in Methods). The combination of automation, converting pixel intensities to absorbance values, calculating absorbance confidence, and establishing microscope equilibrium through benchmarking ensures the quality of image data captured with QBAM. The robustness of QBAM was validated in 3 systems to ensure the measurement could be used in multiple circumstances: (a) synthetic standards ( Figure 2, A and B) , (b) healthy biological samples ( Figure 2C and Supplemental Figure 3) , and (c) druginduced models of iPSC-RPE maturity (Figure 3 and Supplemental Figure 3 ). Analysis of the QBAM images showed absorbance values agreed with "known" synthetic standards and could assess the development of pigment in both healthy and diseased RPE. The results shown in Figure 2 and Supplemental Figure 3 also highlight the robustness of the measurement across multiple microscopes or imaging configurations. Errors between different microscope measurements of the same sample were within 4.4% of the signal as compared with an average error of 31% on reference standards for VEGF ELISAs (30) and 100% for TER measurements in epithelium (31) . This represents 1 to 2 orders of magnitude reduction in variability for a potential release assay for a cell-therapy product or when used in a drug screening methodology.
QBAM is optimized for determining absorbance for cell types that absorb light. However, results with nonpigmented (severe) albinism cells indicate possible applications on other nonpigmented cell types. Due to the signal-to-noise ratio in these cells being over twice the lower limit of detection, we hypothesize that either absorbance or transmittance data could be broadly applicable to any cell type in culture. Therefore, it may be suitable for assays in which light absorbance is used, such as viable cell counting using trypan blue staining, histological staining, or analysis of light-absorbing biological mine which images came from which donor (TML models) or to identify whether 2 images were from the same donor (DNN-I). The TML algorithms took the features derived from QBAM images as an input and gave a donor identification as an output. In comparison, DNN-I took 2 QBAM images as an input and classified the images as coming from the same or different donors. The TML approach was able to classify the donor identity of RPE cells derived from new clones of a donor when it had been trained on images of RPE cells derived from other clones of that same donor; it was not able to classify "new" donors that were not present in the training data. The DNN-I strategy for binary classification of 2 images as "same" or "not same" gives the DNN-I the potential to classify "new" donors that were not used during training. L-SVM was found to have the highest accuracy of all TML algorithms tested (Supplemental Table 5 ), with an accuracy of 76.4% (2.3× random chance), a sensitivity of 64.6%, and a specificity of 82.3%. Across all donor/sample combinations, DNN-I had better performance with an accuracy of 85.4% (2.6× random chance), a sensitivity of 80.9%, and a specificity of 86.8% (Tables 3 and 4 ). Interestingly, cell-image features that were key to distinguishing AMD iPSC-RPE from each other were similar across different iPSC-RPE combina- the prediction error of iPSC-RPE from multiple AMD donors. We hypothesize 2 reasons for this: (a) healthy-2 iPSC-RPE had a wider range of both TER and VEGF-ratio values due to the inclusion of positive and negative controls than did AMD-iPSC-RPE, which were manufactured using a cGMP-based process with the goal of reproducibly manufacturing healthy mature iPSC-RPE monolayers. (b) The AMD-iPSC-RPE had a larger data set for training, as it included all healthy-2 data as well as the training data from the AMD-iPSC-RPE. In machine learning, more data generally leads to more accurate models; however, implementation of our methodology in any application should give special consideration to ensuring a wide range of conditions (i.e., more donors and positive/negative controls) for training than presented in this proof-of-principle study to ensure the robustness of the model. As expected, deep learning had a lower RMSE of prediction for both TER and VEGF-ratio as compared with the TML approaches. However, using TML approaches allowed discovery of important cell image features ( Figure 5B and Figure 6D ). These 2 approaches were chosen because we perceive 2 motivations for cellular product manufacturers, regulators, clinicians, and/or researchers. Motivation 1 is as follows: often in manufacturing, clinical settings, or high-throughput screens, time is a critical factor and a clear "go/ no-go" or simple readout is desired. In these cases, algorithms that provide the highest accuracy and are most robust to noise should be used, and deep learning is an excellent tool for this application (13, 18) . Motivation 2 is as follows: frequently in research, insight into underlying mechanisms of function are important. In these cases, more scrutable methods in which the importance of cell-image features can be determined are necessary. For this motivation TML approaches are desirable because their underlying architecture is simple enough to be understood and the importance of factors (here cell image features) to predicting tissue function can be obtained.
Feature extraction from QBAM images led to hundreds of features based on the shape, intensity and texture of cells at both the single-cell level and across larger cell populations. Many of these features are mathematical abstractions that lack meaningful connection to cell function. Therefore, even though TML models may be more interpretable than DNNs, the features that compose these models may not be relatable to the underlying biology (37) (38) (39) . Nonetheless, for cell-manufacturing purposes, what these features are and how they relate to the underlying biology are less important than being able to identify their 95% CI and ensuring that future batches/clones from donors fall within this range, making their use here in TML models relevant regardless of their relationship to the underlying biology.
Identification and clustering of iPSC-RPE from clinically relevant donors. Currently, there is a critical need to develop a noninvasive, clinically compatible assay to confirm the quality of cell-therapy products just prior to implantation. The PCA and cluster analysis shown in Figure 7 , A and B, could serve this unmet need. Using this approach, or similar clustering techniques, the similarity of the to-be-implanted article to other technical replicates (or previous successful manufactured batches) can be noninvasively assessed for the first time. Additionally, the donor identification work done using DNN-I or the L-SVM shown in Tables 3-5 and Figure 7C can serve as a QA/QC step to detect simple culture errors, such as switched wells or a flipped plate, and to match identity of this implant to specimens such as pigmented skin cells or dopaminergic neurons that express neuromelanin. In cases in which transmittance values may be preferred, such as histology, the statistics can be modified to generate reproducible images of tissue sections. Also, this methodology is generalizable to any multispectral modality, since none of the calculations are wavelength specific. Finally, we expect that the methods could be suitable for hyperspectral autofluorescent imaging that can identify cell borders and subcellular organization in nonpigmented cells (32) .
Prediction of iPSC-RPE function. Neural networks and machine-learning algorithms were trained with a full range of cell phenotypes by using healthy iPSC-RPE and drugs that were known to inhibit (HPI4) and promote (aphidicolin) iPSC-RPE maturation (21) . Having diverse phenotypes in the training set enhanced the robustness of the algorithms, as was expected from the literature (18) . Additionally, the method worked on 2 different donors, not only as an end-point assay of tissue health, but also as a noninvasive tool for tracking tissue development during the long maturation period (approximately 35 days) (33) . Importantly, the accuracy of the algorithms in predicting both TER and VEGFratio was close to the measurement uncertainty for both TER (31) and VEGF (30, 34) . The generalizability of such metrics across cell lines, regardless of donor, adds to the broad utility of this work, as here we show that even with a limited data set, strong predictive ability, regardless of donor and clone, was shown ( Figure 5 ).
The cut-off ratios for biomanufacturing, 400 Ω·cm 2 for TER and 3.0 for VEGF-ratio, were chosen according to the literature (33, 35, 36) . However, it is important to note that similar accuracies, sensitivities, and specificities were found when assessing a range of TER values from 200 Ω·cm 2 to 1000 Ω·cm 2 or VEGFratio from 1 to 5 and that thresholds should be set according to the manufacturer's specifications. In this study, we observed a higher prediction error for the iPSC-RPE from healthy-2 compared with pixel in the image of the sample. To make the method microscope independent, it includes a protocol of benchmarking a microscope to ensure accuracy of the measurement. Statistical criteria were developed to ensure accurate measurements of absorbance based on metrics obtained from benchmarking. The statistical criteria define the number of images that must be captured to ensure an accuracy of 0.01 absorbance units and are calculated in real time as images are captured. If image data do not meet the criteria, then additional images are captured until there is sufficient information to obtain an accurate measurement. A thorough description of this method is provided in the Supplemental Methods. Culture, assays, and imaging of iPSC-RPE. After differentiation, healthy-1 and healthy-2 iPSC-RPE were placed on fresh Transwell plates for maturation. Beginning 2 weeks or 1 week from the start of the culture, iPSC-RPE were exposed to aphidicolin, HPI4, or neither drug. On the same day that cells were exposed to 1 of the 3 experimental conditions, cells were imaged weekly using QBAM for the duration of cell culture (8 weeks of total culture). A total of 12 images were captured in each well (4 × 3 overlapping grid, 1%-15% overlap). On the same day that cells were imaged, TER was measured and supernatant was collected to measure cytokine release (VEGF).
DNNs. Three main DNNs were created for this work, and the development and training of each of them is described in detail in the Supplemental Methods. The first DNN (DNN-F) was trained to predict TER and VEGF release, where the input image was a 1024 × 1024 pixel, 3-color QBAM image and the output was a TER value and a VEGF value. The second DNN (DNN-S) was trained to identify borders of cells in QBAM images, where the input of the network was a 256 × 256 pixel, 3-color QBAM image and the output was a cell border segmentation. The third network (DNN-I) was trained to take 2 QBAM images of iPSC-RPE and determine whether the images came from the same donor. The training data for this network included iPSC-RPE from multiple donors prepared multiple times from iPSC reprogramming to maturation, and the network learned to identify iPSC-RPE from different preparations of the same donor.
Feature extraction and TML. QBAM images segmented using DNN-S were used to extract cell features using the WIPP (19) . A complete list of features is provided in Supplemental Table 1 . Features were then used as inputs to traditional machine-learning algorithms (MLPs, PLSR, L-SVMs, RF). Details on preprocessing and training parameters are described in detail in the Supplemental Methods. Each of the traditional machine-learning algorithms was used to predict the same metrics of the DNNs (TER, VEGF, donor identity, not segmentation). The advantage of traditional machine-learning algorithms is that it is easier to identify specific cellular features that correlate to predicting cell function or identity.
Quantification and statistical analysis. All significance between groups indicated for albino lines and for Figure 3 , A, D, and E, was determined using a linear mixed effect model controlling for repeated measures from a single well over time and for multiple images being taken per well. These models were assessed using the multicomp and the nlme packages in R. R 2 values, CIs, and Kolmogorov-Smirnov, F-1, and F-2 statistics were calculated in base R. P values of 0.005 or less were considered significant.
Study approval. All iPSC lines were obtained from human subjects in IRB 11-EI-0245 protocol. A total of 15 iPSC-RPE cell lines, obtained from 10 different donors, were used in this paper. The iPSC-RPE other replicates from the same donor. This will be especially important in a facility that manufactures thousands of autologous therapeutics and must confirm the identity of each patient's dose. However, to determine a donor's identity (as with the L-SVM), a reference differentiation and image data set is needed for each patient line generated. This can be partially mitigated by using longitudinal imaging sets during the first culture; however, these models will necessarily be less robust, as the training data will be limited.
The two most important features to identifying the developmental outliers in Figure 7 , A and B, can be seen in Supplemental Figure 7E and were the SD of the maximum intensity (intensity 8) of the iPSC-RPE and the Zernike n5-m3 polynomial (shape 10). The deviation of the max intensity parameter agrees well with absorbance results showing that AMD3 clone A-derived iPSC-RPE had a lower absorbance than iPSC-RPE derived from other clones of AMD3. Zernike polynomials have been useful for detecting invasive cancer cell shapes (40) and in classifying tumors (41) , which leads us to hypothesize these polynomials are also critical to detecting a difference between AMD1 iPSC clone A RPE, which had 894 oncoexome sequence alterations (25) , and iPSC-RPE derived from other AMD clones/donors. We acknowledge that the cluster analysis performed in Figure 7B is not a conclusive proof that the development of oncogene sequence alterations can be identified with only QBAM imaging. However, in a cell therapy manufacturing setting, cluster analysis could be used to screen individual therapy replicates to determine whether there are outliers that might need additional scrutiny. Also, because the assay is noninvasive, this information will provide surgeons with additional confidence in the quality of the actual transplant being delivered to the patient, which has not been possible previously.
In conclusion, the methodology presented here shows that QBAM imaging can be used to assess the pigmentation development of healthy and diseased iPSC-RPE noninvasively. DNNs can analyze these images and accurately predict cell TER and VEGF-ratio across 10 different iPSC-RPE preparations. Additionally, QBAM images contain sufficient information to allow DNNs to accurately segment cell borders of live RPE cells. Once segmented, hundreds of features can be calculated per cell, and using these features, cell function can be predicted, outlier samples can be identified, and donor identity can be confirmed. All of this information can be obtained on the tissue that is being implanted into the patient with an automated bright-field microscope, without the need for expertise from a clinician, in just minutes. Thus, QBAM has potential application in a biomanufacturing setting where thousands of manufactured RPE units could be noninvasively tested and qualified for clinical use by a technician.
Methods
A complete Methods section is provided in the Supplemental Materials. Below is an abbreviated Methods section.
QBAM. We developed a method of determining absorbance values from bright-field images called QBAM. The basic principle of QBAM imaging is absorbance, which is an absolute measurement of light attenuation. Absorbance is calculated using QBAM by capturing an image with the light off, then a second image with the light on but no sample on the stage, and finally an image of the sample. These 3 images are then used to calculate absorbance of every 1 0 2 2 jci.org Volume 130 Number 2 February 2020
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